These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 6813636)
1. Dopaminergic mechanisms regulating prolactin secretion in patients with prolactin-secreting pituitary adenoma. Long-term studies after selective transsphenoidal surgery. Barbarino A; De Marinis L; Anile C; Menini E; Merlini G; Maira G Metabolism; 1982 Nov; 31(11):1100-4. PubMed ID: 6813636 [TBL] [Abstract][Full Text] [Related]
2. Prolactin-secreting pituitary adenomas: prolactin dynamics before and after transsphenoidal surgery. Barbarino A; de Marinis L; Menini E; Anile C; Maira G Acta Endocrinol (Copenh); 1979 Jul; 91(3):397-409. PubMed ID: 112818 [TBL] [Abstract][Full Text] [Related]
3. Serum prolactin response to thyrotropin-releasing hormone and metoclopramide in patients with prolactin-secreting tumors before and after transsphenoidal surgery. Barbarino A; De Marinis L; Maira G; Menini E; Anile C J Clin Endocrinol Metab; 1978 Nov; 47(5):1148-51. PubMed ID: 122421 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of dopaminergic tone in hyperprolactinemia. III. Thyroid-stimulating hormone response to metoclopramide in differential diagnosis and postoperative follow-up of prolactinoma patients. De Marinis L; Mancini A; Minnielli S; Masala R; Anile C; Maira G; Barbarino A Metabolism; 1985 Oct; 34(10):917-22. PubMed ID: 4046835 [TBL] [Abstract][Full Text] [Related]
5. The effect of metoclopramide, TRH and L-dopa on prolactin secretion in pituitary adenoma and in "functional" galactorrhoea syndrome. Jeske W Acta Endocrinol (Copenh); 1979 Jul; 91(3):385-96. PubMed ID: 112817 [TBL] [Abstract][Full Text] [Related]
6. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture. Ishibashi M; Yamaji T J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273 [TBL] [Abstract][Full Text] [Related]
7. Prolactin dynamics in patients with non-secretin tumours of the hypothalamic-pituitary region. Barbarino A; De Marinis L; Mancini A; Menini E; D'Amico C; Passeri M; Sambo P; Anile C; Maira G Acta Endocrinol (Copenh); 1985 Sep; 110(1):10-6. PubMed ID: 3929517 [TBL] [Abstract][Full Text] [Related]
8. [The properties of prolactin secretion in patients with prolactin secreting pituitary adenomas]. Sato S Nihon Naibunpi Gakkai Zasshi; 1987 Aug; 63(8):947-60. PubMed ID: 3123284 [TBL] [Abstract][Full Text] [Related]
9. Postoperative evaluation of dopaminergic tone in prolactinoma patients. II. Plasma thyrotropin response to metoclopramide. De Marinis L; Mancini A; Maira G; Anile C; Menini E; Barbarino A J Clin Endocrinol Metab; 1984 Mar; 58(3):405-9. PubMed ID: 6693543 [TBL] [Abstract][Full Text] [Related]
10. Abnormal regulation of prolactin secretion after successful surgery for prolactin-secreting pituitary tumours. Schlechte JA; Sherman BM Clin Endocrinol (Oxf); 1981 Aug; 15(2):165-74. PubMed ID: 6796301 [TBL] [Abstract][Full Text] [Related]
11. Loss of central nervous system component of dopaminergic inhibition of prolactin secretion in patients with prolactin-secreting pituitary tumors. Fine SA; Frohman LA J Clin Invest; 1978 Apr; 61(4):973-80. PubMed ID: 659585 [TBL] [Abstract][Full Text] [Related]
12. Prolactin-secreting adenomas: surgical results and long-term follow-up. Maira G; Anile C; De Marinis L; Barbarino A Neurosurgery; 1989 May; 24(5):736-43. PubMed ID: 2716983 [TBL] [Abstract][Full Text] [Related]
14. Long term follow-up of women with surgically treated prolactin-secreting pituitary tumors. Schlechte JA; Sherman BM; Chapler FK; VanGilder J J Clin Endocrinol Metab; 1986 Jun; 62(6):1296-301. PubMed ID: 3084539 [TBL] [Abstract][Full Text] [Related]
15. Modulation of postinhibitory increase in plasma prolactin by domperidone in patients with prolactin secreting adenoma. Hanew K; Sato S; Sasaki A; Goh M; Shimizu Y; Murakami O; Yoshinaga K Endocrinol Jpn; 1985 Dec; 32(6):811-7. PubMed ID: 3938732 [TBL] [Abstract][Full Text] [Related]
16. Hypothalamic dopamine is required for salsolinol-induced prolactin secretion in goats. Hashizume T; Watanabe R; Inaba Y; Sawai K; Fülöp F; Nagy GM Anim Sci J; 2017 Oct; 88(10):1588-1594. PubMed ID: 28556305 [TBL] [Abstract][Full Text] [Related]
17. Dynamics of prolactin secretion in patients with hypopituitarism and pituitary macroadenomas. Arafah BM; Nekl KE; Gold RS; Selman WR J Clin Endocrinol Metab; 1995 Dec; 80(12):3507-12. PubMed ID: 8530591 [TBL] [Abstract][Full Text] [Related]
18. Changes in pituitary hormones during and following transsphenoidal removal of prolactinomas. Casper RF; Rakoff JS; Quigley ME; Gilliland B; Alksne J; Yen SS Am J Obstet Gynecol; 1980 Feb; 136(4):518-23. PubMed ID: 6766667 [TBL] [Abstract][Full Text] [Related]
19. The interrelationships between prolactin and thyrotrophin secretion following dopaminergic blockage in patients with mild hyperprolactinaemia without any demonstrable pituitary tumour. Spitz IM; Haas M; Trestian S; Zylber-Haran E; Shilo S Clin Endocrinol (Oxf); 1983 Sep; 19(3):285-94. PubMed ID: 6414745 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of two inhibitory tests (nomifensine and L-dopa + carbidopa) for the diagnosis of hyperprolactinaemic states. Moriondo P; Travaglini P; Nissim M; Faglia G Clin Endocrinol (Oxf); 1980 Dec; 13(6):525-33. PubMed ID: 7226570 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]